Parabilis Medicines, Inc. Line of Credit Facility, Maximum Borrowing Capacity
Parabilis Medicines, Inc. (PBLS) had Line of Credit Facility, Maximum Borrowing Capacity of $60.00 million as of 2024-11-22, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2026-08-13
- 2024-11-22: Line of Credit Facility, Maximum Borrowing Capacity $60.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2024-11-22 | $60.00M 10-Q · filed 2026-08-13 |